Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja Sikjaer

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2013
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatmentTanja Sikjaer, Anne Kristine Amstrup, Lars Rolighed, et al.
European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2018
Prevalence and Risk of Vertebral Fractures in Primary Hyperparathyroidism: A Nested Case-Control StudyHenriette Ejlsmark-Svensson, Lise Sofie Bislev, Siv Lajlev, et al.
Clinical Endocrinology|November 4, 2010
Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional studyAnne Kristine Amstrup, Lars Rejnmark, Peter Vestergaard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 12, 2016
Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in HypothyroidismTanja Sikjaer, Emil Moser, Lars Rolighed, et al.
Journal of Bone and Mineral Metabolism|August 22, 2015
Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal womenAnne Kristine Amstrup, Niels Frederik Breum Jakobsen, Emil Moser, et al.
World Journal of Surgery|October 9, 2013
Muscle function is impaired in patients with "asymptomatic" primary hyperparathyroidismLars Rolighed, Anne Kristine Amstrup, Niels Frederik Breum Jakobsen, et al.
Clinical Endocrinology|May 1, 2020
Changes in treatment needs of hypoparathyroidism during pregnancy and lactation: A case seriesEtki A R Hartogsohn, Aliya A Khan, Line Underbjerg Kjaersulf, et al.
Clinical Endocrinology|May 8, 2018
Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trialLise Sofie Bislev, Lene Langagergaard Rødbro, Jesper Nørgaard Bech, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2013
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatmentTanja Sikjaer, Anne Kristine Amstrup, Lars Rolighed, et al.
European Journal of Endocrinology|February 4, 2015
No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trialLars Rolighed, Lars Rejnmark, Tanja Sikjaer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2018
Prevalence and Risk of Vertebral Fractures in Primary Hyperparathyroidism: A Nested Case-Control StudyHenriette Ejlsmark-Svensson, Lise Sofie Bislev, Siv Lajlev, et al.
Clinical Endocrinology|November 4, 2010
Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls - a cross-sectional studyAnne Kristine Amstrup, Lars Rejnmark, Peter Vestergaard, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 12, 2016
Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in HypothyroidismTanja Sikjaer, Emil Moser, Lars Rolighed, et al.
Journal of Bone and Mineral Metabolism|August 22, 2015
Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal womenAnne Kristine Amstrup, Niels Frederik Breum Jakobsen, Emil Moser, et al.
World Journal of Surgery|October 9, 2013
Muscle function is impaired in patients with "asymptomatic" primary hyperparathyroidismLars Rolighed, Anne Kristine Amstrup, Niels Frederik Breum Jakobsen, et al.
Clinical Endocrinology|May 1, 2020
Changes in treatment needs of hypoparathyroidism during pregnancy and lactation: A case seriesEtki A R Hartogsohn, Aliya A Khan, Line Underbjerg Kjaersulf, et al.
Clinical Endocrinology|May 8, 2018
Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trialLise Sofie Bislev, Lene Langagergaard Rødbro, Jesper Nørgaard Bech, et al.
Pageof 5